Works by Raetz, Elizabeth
Results: 65
Assessment of proxy‐reported responses as predictors of motor and sensory peripheral neuropathy in children with B‐lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30634
- By:
- Publication type:
- Article
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30609
- By:
- Publication type:
- Article
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30585
- By:
- Publication type:
- Article
Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, p. 1, doi. 10.1002/pbc.30585
- By:
- Publication type:
- Article
Minimal residual disease predicts outcomes in KMT2A‐rearranged but not KMT2A‐germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 9, p. 1, doi. 10.1002/pbc.30467
- By:
- Publication type:
- Article
Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 8, p. 1, doi. 10.1002/pbc.30420
- By:
- Publication type:
- Article
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Activation of the mitogen‐activated protein kinase–extracellular signal‐regulated kinase pathway in childhood B‐cell acute lymphoblastic leukemia.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 10, p. 1, doi. 10.1002/pbc.29771
- By:
- Publication type:
- Article
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28929
- By:
- Publication type:
- Article
Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28843
- By:
- Publication type:
- Article
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated <italic>Erwinia</italic> asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 3, p. 1, doi. 10.1002/pbc.26873
- By:
- Publication type:
- Article
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular pathogenesis of T-cell leukaemia and lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2248803, doi. 10.1001/jamanetworkopen.2022.48803
- By:
- Publication type:
- Article
Potential of Gene Expression Profiling in the Management of Childhood Acute Lymphoblastic Leukemia.
- Published in:
- Pediatric Drugs, 2007, v. 9, n. 3, p. 149, doi. 10.2165/00148581-200709030-00003
- By:
- Publication type:
- Article
Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e2014205, doi. 10.1001/jamanetworkopen.2020.14205
- By:
- Publication type:
- Article
A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 2, p. 221, doi. 10.1002/cam4.583
- By:
- Publication type:
- Article
Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 274, doi. 10.1111/bjh.15919
- By:
- Publication type:
- Article
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 843, doi. 10.1111/bjh.14258
- By:
- Publication type:
- Article
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 1, p. 87, doi. 10.1111/bjh.13011
- By:
- Publication type:
- Article
The future role of monoclonal antibody therapy in childhood acute leukaemias.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 1, p. 3, doi. 10.1111/bjh.12002
- By:
- Publication type:
- Article
Immunotherapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Advances and Ongoing Challenges.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 5, p. 485, doi. 10.1007/s40272-020-00413-3
- By:
- Publication type:
- Article
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
- Published in:
- Nature Communications, 2015, v. 6, n. 6, p. 7553, doi. 10.1038/ncomms8553
- By:
- Publication type:
- Article
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 9, p. 1863, doi. 10.1002/cncr.34150
- By:
- Publication type:
- Article
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131
- Published in:
- 2018
- By:
- Publication type:
- journal article
Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 10, p. e2128385, doi. 10.1001/jamanetworkopen.2021.28385
- By:
- Publication type:
- Article
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Primary T cell central nervous system lymphoblastic lymphoma in a child: case report and literature review.
- Published in:
- Child's Nervous System, 2015, v. 31, n. 6, p. 977, doi. 10.1007/s00381-015-2633-6
- By:
- Publication type:
- Article
SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 745, doi. 10.1002/jha2.697
- By:
- Publication type:
- Article
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 2, p. 332, doi. 10.1002/ijc.29708
- By:
- Publication type:
- Article
SETD2 mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia.
- Published in:
- Leukemia & Lymphoma, 2024, v. 65, n. 1, p. 78, doi. 10.1080/10428194.2023.2273752
- By:
- Publication type:
- Article
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4.
- Published in:
- Leukemia & Lymphoma, 2019, v. 60, n. 7, p. 1740, doi. 10.1080/10428194.2018.1542146
- By:
- Publication type:
- Article
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 7, p. 1624, doi. 10.1080/10428194.2017.1397658
- By:
- Publication type:
- Article
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.
- Published in:
- Nature Genetics, 2013, v. 45, n. 3, p. 290, doi. 10.1038/ng.2558
- By:
- Publication type:
- Article
Impact of microarray technology in clinical oncology.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13069-6
- By:
- Publication type:
- Article
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1847, doi. 10.3390/cancers13081847
- By:
- Publication type:
- Article
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: A report from the children's oncology group.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 3, p. 414, doi. 10.1002/pbc.25311
- By:
- Publication type:
- Article
Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 10, p. 1779, doi. 10.1002/pbc.25119
- By:
- Publication type:
- Article